Production (Stage)
Vicarious Surgical Inc.
RBOT
$8.09
$0.111.38%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.54% | 18.52% | -12.40% | 10.56% | -29.67% |
| Total Depreciation and Amortization | -31.92% | 6.90% | -5.59% | 3.07% | -0.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.17% | -26.91% | 97.93% | -66.19% | 206.51% |
| Change in Net Operating Assets | 126.87% | -195.03% | -63.80% | 176.51% | -739.38% |
| Cash from Operations | 0.17% | 7.10% | -15.13% | 23.77% | -27.16% |
| Capital Expenditure | 97.22% | -1,225.00% | 366.67% | 40.00% | 99.04% |
| Sale of Property, Plant, and Equipment | -- | -200.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.47% | 2,900.19% | 92.47% | -5,082.84% | -102.20% |
| Cash from Investing | -68.08% | 3,036.99% | 92.92% | -4,727.08% | -102.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 183.33% | -- | -- | -100.00% | -94.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 183.33% | -- | -- | -100.00% | -94.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -367.54% | 120.24% | 26.66% | -23.10% | -132.08% |